{"altmetric_id":21094142,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":2},"facebook":{"unique_users_count":1,"unique_users":["100342973965"],"posts_count":2}},"citation":{"altmetric_jid":"4f6fa5ea3cf058f610005bde","authors":["Fuerst, Mark L."],"doi":"10.1097\/01.cot.0000520698.35798.1c","first_seen_on":"2017-06-15T22:48:05+00:00","issns":["0276-2234"],"issue":"11","journal":"Oncology times","last_mentioned_on":1497978619,"links":["http:\/\/journals.lww.com\/oncology-times\/Fulltext\/2017\/06100\/Debate__Post_Transplant_Maintenance_With.22.aspx"],"pdf_url":"http:\/\/pdfs.journals.lww.com\/oncology-times\/2017\/06100\/Debate__Post_Transplant_Maintenance_With.22.pdf","pubdate":"2017-06-10T00:00:00+00:00","publisher":"LWW","startpage":"30","title":"Debate","type":"article","uri":"http:\/\/journals.lww.com\/oncology-times\/Fulltext\/2017\/06100\/Debate__Post_Transplant_Maintenance_With.22.aspx","volume":"39"},"altmetric_score":{"score":0.25,"score_history":{"1y":0.25,"6m":0.25,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":8396916,"mean":7.0724322720827,"rank":7258194,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":8396916,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":242682,"mean":12.708709408647,"rank":198370,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":242682,"percentile":1},"this_journal":{"total_number_of_other_articles":1941,"mean":4.7649783505155,"rank":1831,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1941,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":127,"mean":6.5579365079365,"rank":127,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":127,"percentile":1}}},"demographics":[],"posts":{"facebook":[{"title":"Timeline Photos","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10155451444103966&id=100342973965","license":"public","citation_ids":[21094142],"posted_on":"2017-06-14T21:55:09+00:00","summary":"Debate: Post-Transplant Maintenance With Lenalidomide for Multiple Myeloma \n\nLenalidomide maintenance should be the standard of care post-transplant for patients with multiple myeloma, but high-risk patients may be considered for combination therapy, accor","author":{"name":"Oncology Times","url":"https:\/\/www.facebook.com\/100342973965","facebook_wall_name":"Oncology Times","image":"https:\/\/graph.facebook.com\/100342973965\/picture","id_on_source":"100342973965"}},{"title":"Timeline Photos","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10155483581903966&id=100342973965","license":"public","citation_ids":[21094142],"posted_on":"2017-06-20T17:10:19+00:00","summary":"Debate: Post-Transplant Maintenance With Lenalidomide for Multiple Myeloma \n\nLenalidomide maintenance should be the standard of care post-transplant for patients with multiple myeloma, but high-risk patients may be considered for combination therapy, accor","author":{"name":"Oncology Times","url":"https:\/\/www.facebook.com\/100342973965","facebook_wall_name":"Oncology Times","image":"https:\/\/graph.facebook.com\/100342973965\/picture","id_on_source":"100342973965"}}]}}